REGISTERED
on 29 May 2018
Last Applicant/ Owned by
650 Chapel St SOUTH YARRA VIC 3141
AU
Serial Number
79210373 filed on 07th Dec 2016
Registration Number
5477686 registered on 29th May 2018
Correspondent Address
Richard M. LaBarge
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
OPTHEA
Advisory services relating to scientific research; Laboratory services, namely, scientific research or analysis in the field of ophthalmology; Management of scientific research projects; Medical research and scientific research for medical purposes; Preparation of reports relating to scientific research; Preparation of scientific reports; Providing information, including online, about scientific a Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Advisory services relating to scientific research; Laboratory services, namely, scientific research or analysis in the field of ophthalmology; Management of scientific research projects; Medical research and scientific research for medical purposes; Preparation of reports relating to scientific research; Preparation of scientific reports; Providing information, including online, about scientific and technological services and research and design relating thereto, namely for scientific research, analyses and testing in the field of ophthalmology; Provision of information relating to scientific research; Provision of scientific information in the field of ophthalmology; Scientific advisory services in the field of ophthalmology; Scientific analysis in the field of ophthalmology; Technical analysis for research and testing in the field of ophthalmology; Scientific and technological services namely for scientific research, analysis and testing in the field of ophthalmology; Scientific consultancy relating to ophthalmic conditions; Scientific laboratory services; Scientific research; Scientific research in the field of pharmacy; Scientific research into the development of new products; Scientific research relating to bacteriology; Scientific research relating to biology; Scientific research relating to chemical products; Scientific research relating to chemistry; Scientific research relating to genetics; Scientific testing services in the field of ophthalmology; Bacteriological research; Biochemistry research services; Biological research; Biotechnological research; Biotechnology research; Chemical research; Chemical technological research; Genetic research; Laboratory research; Medical research; Pharmaceutical research services; Providing information, including online, about industrial analysis and research services namely for scientific research, analyses and testing in the field of ophthalmology; Provision of medical, veterinary, biological and pharmaceutical research services in the field of ophthalmology; Research and development of new products for others; Research and development of products; Research into the development of new products; Research laboratories in the field of ophthalmology; Research relating to bacteriology; Research relating to biotechnology; Research relating to chemicals; Research relating to chemistry; Research relating to medicine; Research relating to molecular sciences; Research relating to pharmaceuticals; Research relating to science; Research to develop new products; Services for assessing the efficiency of pharmaceuticals namely pharmaceutical product evaluation; Services for assessing the safety of pharmaceuticals, namely testing, inspection or research of pharmaceuticals; Chemical analysis; Laboratory analysis in the field of ophthalmology; Analysis of tissues for medical research; Design of medical apparatus; Medical laboratory services; Analytical laboratory services, namely analysis of tissue samples or bodily fluids for diagnostic purposes; Chemical laboratory services; Laboratory testing services, namely testing of tissue samples or bodily fluids for diagnostic purposes; Veterinary laboratory services; Information in the field of chemical research; Testing of chemicals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Biological preparations for pharmaceutical purposes for the treatment of ophthalmic conditions; Chemical preparations for pharmaceutical purposes for the treatment of ophthalmic conditions; Chemical products, namely, sugars, proteins and nucleic acids for pharmaceutical use for the treatment of ophthalmic conditions; Chemicals for pharmaceutical use for the treatment of ophthalmic conditions; Pharmaceutical compositions for the treatment of ophthalmic conditions; Pharmaceutical creams for the treatment of ophthalmic conditions; Pharmaceutical drugs for the treatment of ophthalmic conditions; Pharmaceutical preparations for the treatment of ophthalmic conditions; Pharmaceutical preparations for animals for the treatment of ophthalmic conditions; Pharmaceutical preparations for human use for the treatment of ophthalmic conditions; Pharmaceutical preparations for personal use for the treatment of ophthalmic conditions; Pharmaceutical preparations for veterinary use for the treatment of ophthalmic conditions; Pharmaceutical products for the treatment of ophthalmic conditions; Pharmaceutical products for use by humans for the treatment of ophthalmic conditions; Pharmaceutical substances for the treatment of ophthalmic conditions; Veterinary medicaments for the treatment of ophthalmic conditions; Veterinary preparations for the treatment of ophthalmic conditions; Veterinary products for the treatment of ophthalmic conditions; Biological preparations for medical purposes for the treatment of ophthalmic conditions; Biological preparations for use in biotechnology for the treatment of ophthalmic conditions; Biological preparations for use in cell cultures, namely in culture media for cultivating human, animal, plant or microorganism cells for medical use; Biological preparations for veterinary purposes for the treatment of ophthalmic conditions; Biological products for medical use, namely for the treatment of ophthalmic conditions; Biological reagents for use in molecular biology for medical use; Biological substances for medical use, namely, biologics, antibodies, monoclonal antibodies, cells and cellular tissues for medical use, namely for the treatment of ophthalmic conditions; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Chemical products, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for use in biology for medical or veterinary use, namely for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Therapeutic biological products, namely, biologics, antibodies, monoclonal antibodies, cells and cellular tissues for medical use, namely for the treatment of ophthalmic conditions; Medical preparations for the treatment of ophthalmic conditions; Substances for use in genetic probe assay kits for medical use, namely, medical diagnostic reagents and assays for testing body fluids; Substances for veterinary use produced by genetic engineering, namely, genetically engineered tissues for transplant purposes; Cultures of cell media for medical use; Cultures of cell media for veterinary purposes; Chemical products for medical or veterinary laboratory use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical preparations for medical analysis purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical preparations for medical purposes for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical preparations for veterinary purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for analysis for medical purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for analysis for veterinary purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for biotechnological purposes for medical uses, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for biotechnological purposes for veterinary use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for medical or veterinary diagnostic purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for medical diagnostic use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for veterinary diagnostic use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions; Chemical products for medical use, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for use in medical science, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemical products for use in science for medical or veterinary purposes, namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions, or, for the treatment of ophthalmic conditions; Chemicals for use in medical and veterinary analysis , namely, biologics, sugars, proteins, nucleic acids and pharmaceuticals for the diagnosis of ophthalmic conditions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79210373
Mark Type
No Service Mark
Attorney Docket Number
No 28967/60000
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 22nd May 2024 | TEAS SECTION 71 RECEIVED |
| 29th May 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 15th Dec 2022 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| 03rd Dec 2022 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
| 02th Jan 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| 28th Sep 2018 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 12th Sep 2018 | FINAL DISPOSITION PROCESSED |
| 12th Sep 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| 29th Aug 2018 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 29th May 2018 | REGISTERED-PRINCIPAL REGISTER |